These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30031888)

  • 1. Proinflammatory cytokines and ageing of the cardiovascular-renal system.
    Smykiewicz P; Segiet A; Keag M; Żera T
    Mech Ageing Dev; 2018 Oct; 175():35-45. PubMed ID: 30031888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune and inflammatory mechanisms mediate cardiovascular diseases from head to toe.
    Libby P; Mallat Z; Weyand C
    Cardiovasc Res; 2021 Nov; 117(13):2503-2505. PubMed ID: 34698765
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of infiltrating immune cells in dysfunctional adipose tissue.
    Guzik TJ; Skiba DS; Touyz RM; Harrison DG
    Cardiovasc Res; 2017 Jul; 113(9):1009-1023. PubMed ID: 28838042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines as therapeutic targets for cardio- and cerebrovascular diseases.
    Liberale L; Ministrini S; Carbone F; Camici GG; Montecucco F
    Basic Res Cardiol; 2021 Mar; 116(1):23. PubMed ID: 33770265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein and ageing.
    Tang Y; Fung E; Xu A; Lan HY
    Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():9-14. PubMed ID: 28378496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrafine carbon particle mediated cardiovascular impairment of aged spontaneously hypertensive rats.
    Upadhyay S; Stoeger T; George L; Schladweiler MC; Kodavanti U; Ganguly K; Schulz H
    Part Fibre Toxicol; 2014 Sep; 11():36. PubMed ID: 25442699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Innate Immune System and Cardiovascular Disease in ESKD: Monocytes and Natural Killer Cells.
    Dounousi E; Duni A; Naka KK; Vartholomatos G; Zoccali C
    Curr Vasc Pharmacol; 2021; 19(1):63-76. PubMed ID: 32600233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunometabolic function of cholesterol in cardiovascular disease and beyond.
    Yvan-Charvet L; Bonacina F; Guinamard RR; Norata GD
    Cardiovasc Res; 2019 Jul; 115(9):1393-1407. PubMed ID: 31095280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urotensin II: a cardiovascular and renal update.
    Zoccali C; Mallamaci F
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):199-204. PubMed ID: 18277155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and Vascular Ageing: From Telomeres to Novel Emerging Mechanisms.
    Chiriacò M; Georgiopoulos G; Duranti E; Antonioli L; Puxeddu I; Nannipieri M; Rosada J; Blandizzi C; Taddei S; Virdis A; Masi S
    High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):321-329. PubMed ID: 31325087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases.
    Damen MSMA; Popa CD; Netea MG; Dinarello CA; Joosten LAB
    Atherosclerosis; 2017 Sep; 264():83-91. PubMed ID: 28716457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fuel for thought: immunometabolism is a paradigm shift in understanding immunity in cardiovascular disease.
    Caligiuri G; Norata GD
    Cardiovasc Res; 2019 Jul; 115(9):1383-1384. PubMed ID: 31199480
    [No Abstract]   [Full Text] [Related]  

  • 13. The heart of immunology: immune mechanisms in cardiovascular medicine.
    Hansson GK
    Cardiovasc Res; 2021 Nov; 117(13):e166-e168. PubMed ID: 34849629
    [No Abstract]   [Full Text] [Related]  

  • 14. [Proinflammatory cytokines in cardiovascular diseases as potential therapeutic target].
    Bielecka-Dabrowa A; Wierzbicka M; Goch JH
    Wiad Lek; 2007; 60(9-10):433-8. PubMed ID: 18350717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNFα Treatment.
    Lazúrová I; Tomáš Ľ
    Clin Rev Allergy Immunol; 2017 Jun; 52(3):323-332. PubMed ID: 27342458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease.
    Chow BS; Allen TJ
    Clin Sci (Lond); 2016 Aug; 130(15):1307-26. PubMed ID: 27358027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytokines, metalloproteinases, neopterin and cardiovascular mortality among patients with chronic renal failure].
    Kościów K; Małecki R; Adamiec R
    Pol Merkur Lekarski; 2007 Jan; 22(127):54-7. PubMed ID: 17477092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Markers in Cardiovascular Disease; Lessons Learned and Future Perspectives.
    Patoulias D; Stavropoulos K; Imprialos K; Athyros V; Grassos H; Doumas M; Faselis C
    Curr Vasc Pharmacol; 2021; 19(3):323-342. PubMed ID: 32188386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage Biology in Cardiovascular Diseases.
    Khoury MK; Yang H; Liu B
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):e77-e81. PubMed ID: 33054391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.